<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Three patients with neuro-<z:chebi fb="6" ids="22696">Beh</z:chebi>Ã§et underwent MRI and MRS during <z:hpo ids='HP_0011009'>acute</z:hpo> illness </plain></SENT>
<SENT sid="1" pm="."><plain>After therapy, MRI and MRS were performed in 3 and 1 patients, respectively </plain></SENT>
<SENT sid="2" pm="."><plain>MRI revealed a marked improvement of the initial lesion in 2, a complete remission in 1 patient </plain></SENT>
<SENT sid="3" pm="."><plain>MRS showed a reduction of the N-<z:chebi fb="9" ids="46887">acetyl</z:chebi>-<z:chebi fb="0" ids="29995">aspartate</z:chebi> (<z:chebi fb="8" ids="32918">NAA</z:chebi>)/phosphocreatine (CR) ratio within the <z:hpo ids='HP_0011009'>acute</z:hpo> lesion in <z:hpo ids='HP_0000001'>all</z:hpo> patients and a normalization in the follow-up spectrum of the examined patient </plain></SENT>
</text></document>